Boxer Capital as of June 30, 2016
Portfolio Holdings for Boxer Capital
Boxer Capital holds 23 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Beigene (BGNE) | 13.0 | $15M | 494k | 29.80 | |
| Blueprint Medicines (BPMC) | 12.7 | $14M | 705k | 20.25 | |
| Seattle Genetics | 8.3 | $9.4M | 233k | 40.41 | |
| Incyte Corporation (INCY) | 7.1 | $8.0M | 100k | 79.98 | |
| Regeneron Pharmaceuticals (REGN) | 6.2 | $7.0M | 20k | 349.25 | |
| Acadia Healthcare (ACHC) | 5.8 | $6.5M | 201k | 32.46 | |
| Tesaro | 5.6 | $6.3M | 75k | 84.05 | |
| Clovis Oncology | 5.5 | $6.2M | 450k | 13.72 | |
| Aquinox Pharmaceuticals | 5.2 | $5.8M | 878k | 6.62 | |
| BioMarin Pharmaceutical (BMRN) | 4.8 | $5.4M | 70k | 77.80 | |
| Avexis | 4.8 | $5.4M | 143k | 38.02 | |
| Aradigm | 4.3 | $4.8M | 1.1M | 4.37 | |
| Mirati Therapeutics | 3.7 | $4.1M | 758k | 5.46 | |
| Syndax Pharmaceuticals (SNDX) | 2.0 | $2.3M | 234k | 9.85 | |
| Akari Therapeutics | 1.7 | $1.9M | 140k | 13.49 | |
| Eiger Biopharmaceuticals | 1.6 | $1.8M | 93k | 19.82 | |
| Kura Oncology (KURA) | 1.5 | $1.7M | 634k | 2.71 | |
| Eleven Biotherapeutics | 1.5 | $1.7M | 1.0M | 1.67 | |
| Aldeyra Therapeutics (ALDX) | 1.5 | $1.7M | 291k | 5.69 | |
| Rigel Pharmaceuticals (RIGL) | 1.4 | $1.6M | 700k | 2.23 | |
| Nabriva Therapeutics | 1.2 | $1.3M | 177k | 7.50 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.6 | $720k | 155k | 4.65 | |
| Essa Pharma | 0.1 | $83k | 28k | 2.95 |
